Csl Ltd ADR (CSLLY)
79.7100 +1.3600 (+1.74%) 11:25 ET [OTC US]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
for Wed, Apr 30th, 2025
Results
download Want to compare other data? Select Fields| Symbol | CSLLY | GSK | REGN | ||
| Company | Csl Ltd ADR | Gsk Plc ADR | Regeneron Pharmaceuticals | ||
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | ||
| Open | 79.2115 | 40.18 | 579.26 | ||
| High | 79.8700 | 40.38 | 585.00 | ||
| Low | 79.0750 | 39.59 | 566.99 | ||
| Last | 79.7100 | 39.74 | 580.18 | ||
| Change | +1.3600 | +0.77 | +11.27 | ||
| % Change | +1.74% | +1.98% | +1.98% | ||
| Volume | 10,619 | 3,889,791 | 425,411 | ||
| 20-Day Average Volume | 114,931 | 6,432,282 | 1,165,127 | ||
| Previous Close | 78.3500 | 38.97 | 568.91 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 76.8980 | 36.45 | 577.80 | ||
| 20-Day Raw Stochastic | 81.24% | 93.75% | 53.87% | ||
| 20-Day Relative Strength | 52.55% | 62.08% | 43.53% | ||
| Weighted Alpha | -16.02 | -2.53 | -44.35 | ||
| Today's Opinion | 72% Sell | 56% Buy | 88% Sell | ||
| Previous Opinion | 88% Sell | 32% Buy | 100% Sell | ||
| Last Month's Opinion | 100% Sell | 32% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.06% since 04/23/25 | +7.70% since 04/23/25 | -1.18% since 04/23/25 | ||
| Low | 76.6850 on 04/24/25 | 36.83 on 04/24/25 | 542.44 on 04/29/25 | ||
| High | 79.7900 on 04/30/25 | 40.38 on 04/30/25 | 614.83 on 04/28/25 | ||
| 1-Month | |||||
| %Chg | +1.06% since 03/28/25 | +2.94% since 03/28/25 | -8.85% since 03/28/25 | ||
| Low | 70.2200 on 04/09/25 | 32.38 on 04/09/25 | 525.99 on 04/09/25 | ||
| High | 82.0000 on 04/02/25 | 40.38 on 04/30/25 | 641.24 on 04/01/25 | ||
| 3-Month | |||||
| %Chg | -8.47% since 01/30/25 | +12.78% since 01/30/25 | -14.95% since 01/30/25 | ||
| Low | 70.2200 on 04/09/25 | 32.38 on 04/09/25 | 525.99 on 04/09/25 | ||
| High | 88.8700 on 01/31/25 | 40.81 on 03/10/25 | 748.29 on 03/10/25 | ||
| 6-Month | |||||
| %Chg | -15.97% since 10/30/24 | +7.75% since 10/30/24 | -37.05% since 10/30/24 | ||
| Low | 70.2200 on 04/09/25 | 31.72 on 01/14/25 | 525.99 on 04/09/25 | ||
| High | 96.7900 on 11/05/24 | 40.81 on 03/10/25 | 883.15 on 10/31/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 75,876,016 | 80,404,152 | 62,196,076 | ||
| Shares Outstanding, K | 968,424 | 2,063,232 | 109,325 | ||
| Annual Sales | 14,800,000,000 | 40,095,390,000 | 14,202,000,000 | ||
| Annual Net Income | 2,642,000,000 | 3,290,590,000 | 4,412,600,000 | ||
| Last Quarter Sales | N/A | 10,387,570,000 | 3,789,200,000 | ||
| Last Quarter Net Income | N/A | 559,150,000 | 917,700,000 | ||
| 60-Month Beta | 0.80 | 0.56 | 0.44 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 0.59 on 02/05/25 | 8.22 on 04/29/25 | ||
| Latest Earnings Date | 08/12/24 | 04/30/25 | 04/29/25 | ||
| Most Recent Dividend | 0.600 on 03/11/25 | 0.400 on 02/21/25 | 0.880 on 02/20/25 | ||
| Next Ex-Dividends Date | 03/11/25 | 02/21/25 | 05/20/25 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 9.42 | 15.39 | ||